Cow Advanced Glycation End Product (AGE) Protein (Active)

Este producto es parte de AGE - Advanced Glycation End Product (Receptor)
Product Graph
390€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cow Advanced Glycation End Product (AGE) Protein (Active)
category
Proteins and Peptides
provider
Abbexa
reference
abx651294
tested applications
SDS-PAGE

Description

Cow Advanced Glycation End Product (AGE) Protein (Active) is an active Cow Protein prepared by glycosylation of extracted Bovine Serum Albumin (BSA), catalyzed by CuSO

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Advanced Glycation End Product (AGE)
Host
Cow
Assay Type
Activity: Active
Biological Activity: Glucose and other reducing sugars can react non-enzymatically with the amino groups of proteins to form compounds called advanced glycation end products (AGEs). AGEs exert their cellular functions via the interaction with receptor for advanced glycation end products (RAGE). It has been reported that AGE stimulates the differentiation and proliferation of 3T3, therefore a proliferation assay was conducted using 3T3 cells. Briefly, 3T3 cells were seeded into triplicate wells in 96-well plates at a density of 2,000 cells/well and allowed to attach overnight, then the medium was replaced with serum-free DMEM prior to the addition of various concentrations of AGE. After incubation for 48 h, cells were observed by inverted microscope (Figures 1 and 2) and cell proliferation was measured by Cell Counting Kit-8 (CCK-8) assay (Figure 3). Briefly, 10 µl of CCK-8 solution was added to each well of the plate, then the absorbance at 450nm was measured using a microplate reader after incubating the plate for 1-4 hours at 37 °C.
Origin
Cow
Conjugation
Unconjugated
Expression
Native
Purity
> 90% (SDS-PAGE)
Purification
Purified by salt co-precipitation and ion-exchange chromatography.
Size 1
50 µg
Size 2
100 µg
Size 3
200 µg
Size 4
1 mg
Size 5
5 mg
Form
Lyophilized
Tested Applications
SDS-PAGE
Buffer
Prior to lyophilization: 10 mM PBS, pH 7.4, containing 5% Trehalose.
Availability
Shipped within 5-15 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
Alias
AGE
Background
Protein AGE
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in 10 mM PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in 10 mM PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Endotoxin Level: < 1.0 EU/µg protein (LAL method)
Concentration: Prior to lyophilization: 2000 µg/ml

Descripción

Advanced Glycation End Products (AGEs) are a diverse group of molecules formed through the non-enzymatic reaction of reducing sugars with proteins, lipids, or nucleic acids in a process called glycation. AGEs accumulate under conditions of oxidative stress and hyperglycemia, particularly in diseases like diabetes mellitus, where they are formed in excess. They are commonly found in long-lived proteins such as collagen and elastin, contributing to tissue stiffness and organ dysfunction. AGEs can crosslink proteins, disrupt cellular signaling, and impair extracellular matrix structure. They are also known to interact with specific receptors, such as the AGE receptor (AGER), activating inflammatory and oxidative pathways that lead to chronic conditions such as cardiovascular disease, kidney damage, and neurodegeneration. AGEs are considered major contributors to aging and the progression of age-related diseases, making them significant biomarkers and therapeutic targets.

Related Products

EH0622

Human AGE (Advanced glycation end-product) ELISA Kit

Ver Producto
EM0716

Mouse AGE (advanced glycation end product) ELISA Kit

Ver Producto
ER0268

Rat AGE (Advanced glycation end-product) ELISA Kit

Ver Producto